Annual Shareholders Equity
$50.30 M
-$33.64 M-40.07%
December 31, 2022
Summary
- As of February 8, 2025, AGLE annual stockholders equity is $50.30 million, with the most recent change of -$33.64 million (-40.07%) on December 31, 2022.
- During the last 3 years, AGLE annual shareholders equity has fallen by -$9.78 million (-16.27%).
Performance
AGLE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
-$245.40 M
-$38.03 M-18.34%
September 30, 2023
Summary
- As of February 8, 2025, AGLE quarterly stockholders equity is -$245.40 million, with the most recent change of -$38.03 million (-18.34%) on September 30, 2023.
- Over the past year, AGLE quarterly shareholders equity has dropped by -$312.96 million (-463.26%).
Performance
AGLE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AGLE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.1% | -463.3% |
| 3 y3 years | -16.3% | -280.1% |
| 5 y5 years | -0.1% | -485.4% |
AGLE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.1% | at low | -391.6% | at low |
| 5 y | 5-year | -64.0% | at low | -261.2% | at low |
| alltime | all time | -64.0% | -96.3% | -261.2% | at low |
Aeglea BioTherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$245.40 M(+18.3%) |
| Jun 2023 | - | -$207.37 M(-716.2%) |
| Mar 2023 | - | $33.65 M(-33.1%) |
| Dec 2022 | $50.30 M(-40.1%) | $50.30 M(-25.5%) |
| Sep 2022 | - | $67.56 M(-19.7%) |
| Jun 2022 | - | $84.16 M(+36.5%) |
| Mar 2022 | - | $61.66 M(-26.5%) |
| Dec 2021 | $83.94 M(-40.0%) | $83.94 M(-17.8%) |
| Sep 2021 | - | $102.08 M(-14.2%) |
| Jun 2021 | - | $119.02 M(-3.8%) |
| Mar 2021 | - | $123.75 M(-11.5%) |
| Dec 2020 | $139.83 M(+132.7%) | $139.83 M(+2.6%) |
| Sep 2020 | - | $136.27 M(-10.5%) |
| Jun 2020 | - | $152.26 M(+255.7%) |
| Mar 2020 | - | $42.80 M(-28.8%) |
| Dec 2019 | $60.08 M | $60.08 M(-24.7%) |
| Sep 2019 | - | $79.80 M(-19.9%) |
| Jun 2019 | - | $99.61 M(-14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $116.29 M(+72.5%) |
| Dec 2018 | $67.43 M(+34.0%) | $67.43 M(+5.9%) |
| Sep 2018 | - | $63.68 M(-13.3%) |
| Jun 2018 | - | $73.45 M(+67.2%) |
| Mar 2018 | - | $43.92 M(-12.7%) |
| Dec 2017 | $50.34 M(-20.1%) | $50.34 M(-9.3%) |
| Sep 2017 | - | $55.51 M(-11.3%) |
| Jun 2017 | - | $62.60 M(+9.5%) |
| Mar 2017 | - | $57.18 M(-9.2%) |
| Dec 2016 | $62.97 M(+74.4%) | $62.97 M(-7.7%) |
| Sep 2016 | - | $68.20 M(-7.7%) |
| Jun 2016 | - | $73.92 M(+133.2%) |
| Mar 2016 | - | $31.70 M(-12.2%) |
| Dec 2015 | $36.10 M(+1828.6%) | $36.10 M(-8.9%) |
| Sep 2015 | - | $39.65 M(-7.6%) |
| Jun 2015 | - | $42.90 M(-0.5%) |
| Mar 2015 | - | $43.12 M(+2203.4%) |
| Dec 2014 | $1.87 M(-41.2%) | $1.87 M |
| Dec 2013 | $3.19 M | - |
FAQ
- What is Aeglea BioTherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics annual shareholders equity year-on-year change?
- What is Aeglea BioTherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics quarterly shareholders equity year-on-year change?
What is Aeglea BioTherapeutics annual stockholders equity?
The current annual shareholders equity of AGLE is $50.30 M
What is the all time high annual shareholders equity for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high annual stockholders equity is $139.83 M
What is Aeglea BioTherapeutics annual shareholders equity year-on-year change?
Over the past year, AGLE annual stockholders equity has changed by -$33.64 M (-40.07%)
What is Aeglea BioTherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of AGLE is -$245.40 M
What is the all time high quarterly shareholders equity for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high quarterly stockholders equity is $152.26 M
What is Aeglea BioTherapeutics quarterly shareholders equity year-on-year change?
Over the past year, AGLE quarterly stockholders equity has changed by -$312.96 M (-463.26%)